CapsoVision (CV) Income from Continuing Operations (2024 - 2026)
CapsoVision (CV) posted Income from Continuing Operations of 7394000.0 for Q4 2025, up 6.65% sequentially from 7921000.0 in Q3 2025, and down 59.39% YoY from 18206351.38 in Q4 2024.
CapsoVision (CV) Income from Continuing Operations (2024 - 2026) Analysis & Trends
CapsoVision has reported Income from Continuing Operations for 2 years, with the latest figure at 7394000.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 59.39% year-over-year to 7394000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 24579000.0 (changed N/A YoY) and the FY2025 annual result came in at 25315000.0, down 27.22% from the prior year.
- Income from Continuing Operations grew to 7394000.0 in Q4 2025 per CV's latest filing, from 7921000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4625000.0 in Q2 2025 and troughed at 7921000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | -7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.48 Mn |
| Dec 31, 2025 | -7.39 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -4.64 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.27 Mn |